Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2018, Vol. 27 ›› Issue (5): 418-423.DOI: 10.3969/j.issn.1006-298X.2018.05.004
• Article • Previous Articles Next Articles
Online:
Published:
Abstract:
Objective:To explore the clinical features,treatment and prognosis of systemic lupus erythematosus (SLE) patients with posterior reversible encephalopathy syndrome (PRES). Methodology:Sixteen SLE patients with PRES were enrolled into this retrospective studyTheir pathogenesis,risk factors,treatment and prognosis were investigated. Results:They were 14 female and 2 male with a mean age of (228±85) years old(ranged from 9 to 43).All 16 cases had high systemic activity,the mean SLEDAI score was (209±37).15 cases(938%) had hypertension,12 cases(75%) had renal insufficiency,low lymphocyte count,dyslipidemia,and all of cases(100%) used hormones or immunosuppressants.Clinical manifestations included seizures in 16 (100%),headache in 5 (31%),visual disturbances in 5 (31%),and nausea and vomiting in 6 (38%).CT and magnetic resonance imaging (MRI) showed that the lesions were mostly located in bilateral parietooccipital lobes.Temporal lobes,frontal lobes,ventricles,basal ganglia,cerebellum,and cortex may also be involved in.Antihypertensive,antiepileptic and lowdose glucocorticoids relieve symptoms. Conclusion:SLE patients with PRES is a clinicalimaging syndrome,which often associated with hypertension,renal insufficiency and systemic disease activity.Clinical manifestations include headache,visual disturbances,seizures,nausea and vomiting.Brain imaging manifests as subcortical vasogenic edema in the bilateral parietooccipital area.Early diagnosis and treatment generally predicates good prognosis.
Key words: systemic lupus erythematosus, posterior reversible encephalopathy syndrome, image
HU Nana,DONG Jianhua,XU Shutian,et al. Characteristics of posterior reversible encephalopathy syndrome associated with systemic lupus erythematosus[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(5): 418-423.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.njcndt.com/EN/10.3969/j.issn.1006-298X.2018.05.004
http://www.njcndt.com/EN/Y2018/V27/I5/418